Steven M. Holland

99.2k total citations · 17 hit papers
738 papers, 47.6k citations indexed

About

Steven M. Holland is a scholar working on Immunology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Steven M. Holland has authored 738 papers receiving a total of 47.6k indexed citations (citations by other indexed papers that have themselves been cited), including 380 papers in Immunology, 237 papers in Epidemiology and 182 papers in Infectious Diseases. Recurrent topics in Steven M. Holland's work include Immunodeficiency and Autoimmune Disorders (197 papers), Mycobacterium research and diagnosis (123 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (116 papers). Steven M. Holland is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (197 papers), Mycobacterium research and diagnosis (123 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (116 papers). Steven M. Holland collaborates with scholars based in United States, United Kingdom and Germany. Steven M. Holland's co-authors include Alexandra F. Freeman, Harry L. Malech, Kenneth N. Olivier, John I. Gallin, Susan E. Dorman, Jennifer M. Puck, Brahm H. Segal, David G. Harrison, Sergey Dikalov and Ulf Landmesser and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Steven M. Holland

708 papers receiving 46.6k citations

Hit Papers

An Official ATS/IDSA Statement: Diagnosis, Treatment, and... 1999 2026 2008 2017 2007 2003 2000 2003 2008 1000 2.0k 3.0k 4.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases
    2007 4.3k citations David E. Griffith, Timothy R. Aksamit et al. American Journal of Respiratory and Critical Care Medicine profile →
  2. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension
    2003 1.2k citations Ulf Landmesser, Steven M. Holland et al. profile →
  3. Chronic Granulomatous Disease: Report on a National Registry of 368 Patients
    2000 1.2k citations Harry L. Malech, Steven M. Holland et al. profile →
  4. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension
    2003 1.2k citations Ulf Landmesser, Steven M. Holland et al. profile →
  5. Impaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome
    2008 848 citations Joshua D. Milner, Alexandra F. Freeman et al. profile →
  6. Human Inborn Errors of Immunity: 2019 Update on the Classification from the International Union of Immunological Societies Expert Committee
    2020 726 citations Stuart G. Tangye, Waleed Al–Herz et al. Journal of Clinical Immunology profile →
  7. JAKs and STATs in Immunity, Immunodeficiency, and Cancer
    2013 662 citations Steven M. Holland et al. profile →
  8. Primary Immunodeficiency Diseases: an Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015
    2015 645 citations Capucine Pïcard, Waleed Al–Herz et al. Journal of Clinical Immunology profile →
  9. Genetic, Biochemical, and Clinical Features of Chronic Granulomatous Disease
    2000 632 citations Harry L. Malech, Steven M. Holland et al. profile →
  10. Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee
    2022 569 citations Stuart G. Tangye, Waleed Al–Herz et al. Journal of Clinical Immunology profile →
  11. Hyper-IgE Syndrome with Recurrent Infections — An Autosomal Dominant Multisystem Disorder
    1999 504 citations Bodo Grimbacher, Steven M. Holland et al. profile →
  12. Prevalence of Nontuberculous Mycobacterial Lung Disease in U.S. Medicare Beneficiaries
    2012 482 citations Jennifer Adjemian, Kenneth N. Olivier et al. American Journal of Respiratory and Critical Care Medicine profile →
  13. International Union of Immunological Societies: 2017 Primary Immunodeficiency Diseases Committee Report on Inborn Errors of Immunity
    2017 479 citations Capucine Pïcard, Waleed Al–Herz et al. Journal of Clinical Immunology profile →
  14. Nontuberculous Mycobacterial Lung Disease Prevalence at Four Integrated Health Care Delivery Systems
    2010 429 citations D. Rebecca Prevots, Amy E. Seitz et al. American Journal of Respiratory and Critical Care Medicine profile →
  15. Human Inborn Errors of Immunity: 2019 Update of the IUIS Phenotypical Classification
    2020 414 citations Aziz Bousfiha, Capucine Pïcard et al. Journal of Clinical Immunology profile →
  16. Primary Immunodeficiency Diseases: An Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency
    2014 402 citations Waleed Al–Herz, Aziz Bousfiha et al. profile →
  17. The 2022 Update of IUIS Phenotypical Classification for Human Inborn Errors of Immunity
    2022 244 citations Aziz Bousfiha, Stuart G. Tangye et al. Journal of Clinical Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steven M. Holland United States 107 21.8k 15.4k 12.0k 7.6k 6.3k 738 47.6k
Anthony S. Fauci United States 158 34.9k 1.6× 20.3k 1.3× 25.0k 2.1× 11.1k 1.5× 3.6k 0.6× 796 95.6k
Yehuda Shoenfeld Israel 115 20.2k 0.9× 7.9k 0.5× 5.5k 0.5× 8.2k 1.1× 6.2k 1.0× 1.6k 63.1k
Barry R. Bloom United States 93 14.1k 0.6× 13.4k 0.9× 13.9k 1.2× 7.0k 0.9× 2.1k 0.3× 333 33.8k
David Y. Graham United States 128 11.5k 0.5× 7.3k 0.5× 10.4k 0.9× 6.5k 0.9× 4.0k 0.6× 944 71.5k
Alain Fischer France 111 25.9k 1.2× 7.0k 0.5× 6.4k 0.5× 14.3k 1.9× 9.7k 1.5× 706 46.7k
H. Clifford Lane United States 77 10.5k 0.5× 7.1k 0.5× 10.0k 0.8× 14.5k 1.9× 3.3k 0.5× 309 42.5k
Akiko Iwasaki United States 91 20.5k 0.9× 8.8k 0.6× 7.4k 0.6× 10.0k 1.3× 1.6k 0.3× 264 36.8k
Philip R. Taylor United States 92 10.7k 0.5× 4.7k 0.3× 2.5k 0.2× 9.5k 1.3× 2.1k 0.3× 511 37.3k
Stefan Schreiber Germany 111 13.6k 0.6× 18.3k 1.2× 4.1k 0.3× 12.9k 1.7× 26.5k 4.2× 896 51.4k
Arturo Casadevall United States 114 7.0k 0.3× 28.1k 1.8× 26.6k 2.2× 12.5k 1.6× 1.4k 0.2× 884 53.1k

Countries citing papers authored by Steven M. Holland

Since Specialization
Citations

This map shows the geographic impact of Steven M. Holland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven M. Holland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven M. Holland more than expected).

Fields of papers citing papers by Steven M. Holland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven M. Holland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven M. Holland. The network helps show where Steven M. Holland may publish in the future.

Co-authorship network of co-authors of Steven M. Holland

This figure shows the co-authorship network connecting the top 25 collaborators of Steven M. Holland. A scholar is included among the top collaborators of Steven M. Holland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven M. Holland. Steven M. Holland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Chandrasekaran, Prabha, Noriko Mitsuiki, Annemarie Gabrysch, et al.. (2025). The intestinal microbiome and metabolome discern disease severity in cytotoxic T-lymphocyte-associated protein 4 deficiency. Microbiome. 13(1). 51–51. 1 indexed citations
3.
Wang, Chen, Amanda Urban, Celeste Nelson, et al.. (2025). Extended clinical phenotypes and long-term outcomes of phosphoglucomutase-3 deficiency. PubMed. 2(2). e20250176–e20250176.
4.
Casanova, Nancy G., Sara M. Camp, Manuel L. Gonzalez‐Garay, et al.. (2023). Examination of eQTL Polymorphisms Associated with Increased Risk of Progressive Complicated Sarcoidosis in European and African Descent Subjects. PubMed. 5(1). 359–371. 1 indexed citations
5.
Tangye, Stuart G., Waleed Al–Herz, Aziz Bousfiha, et al.. (2020). Human Inborn Errors of Immunity: 2019 Update on the Classification from the International Union of Immunological Societies Expert Committee. Journal of Clinical Immunology. 40(1). 24–64. 726 indexed citations breakdown →
6.
7.
Holland, Steven M., et al.. (2019). Clinical and therapeutic features of pulmonary nontuberculous mycobacterial disease, Brazil, 1993-2011. Americanae (AECID Library). 18 indexed citations
8.
Fisher, Kevin E., Amy P. Hsu, Christopher L. Williams, et al.. (2017). Somatic mutations in children with GATA2-associated myelodysplastic syndrome who lack other features of GATA2 deficiency. Blood Advances. 1(7). 443–448. 25 indexed citations
9.
Zhang, Yuan, Chi A., Monica G. Lawrence, et al.. (2017). PD-L1 up-regulation restrains Th17 cell differentiation in STAT3 loss- and STAT1 gain-of-function patients. The Journal of Experimental Medicine. 214(9). 2523–2533. 57 indexed citations
10.
Wan, Chi‐Keung, Allison B. Andraski, Rosanne Spolski, et al.. (2015). Opposing roles of STAT1 and STAT3 in IL-21 function in CD4 + T cells. Proceedings of the National Academy of Sciences. 112(30). 9394–9399. 95 indexed citations
11.
12.
Brennan, Mark A., et al.. (2012). A Mixed-Methods Investigation of Community Attachment in Rural Romania*. Journal of Rural Social Sciences. 27(1). 24. 3 indexed citations
13.
Adjemian, Jennifer, Kenneth N. Olivier, Amy E. Seitz, et al.. (2012). Spatial Clusters of Nontuberculous Mycobacterial Lung Disease in the United States. American Journal of Respiratory and Critical Care Medicine. 186(6). 553–558. 162 indexed citations
14.
Walsh, T. J., Vasilios Pyrgos, Masashi Kasai, et al.. (2009). Bench to bedside: development and implementation of a clinical protocol for the early molecular detection for the improved diagnosis of invasive pulmonary aspergillosis and zygomycosis. Mycoses. 52. 51–52. 1 indexed citations
15.
Wang, Kening, Susan E. Hoover, Erik K. Mont, et al.. (2007). Diverse Herpes Simplex Virus Type 1 Thymidine Kinase Mutants in Individual Human Neurons and Ganglia. Journal of Virology. 81(13). 6817–6826. 32 indexed citations
16.
Doerries, Carola, Karsten Grote, Denise Hilfiker‐Kleiner, et al.. (2007). Critical Role of the NAD(P)H Oxidase Subunit p47 phox for Left Ventricular Remodeling/Dysfunction and Survival After Myocardial Infarction. Circulation Research. 100(6). 894–903. 177 indexed citations
17.
Griffith, David E., Timothy R. Aksamit, Barbara A. Brown‐Elliott, et al.. (2007). An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases. American Journal of Respiratory and Critical Care Medicine. 175(4). 367–416. 4257 indexed citations breakdown →
18.
Dorman, Susan E., Capucine Pïcard, David A. Lammas, et al.. (2004). Clinical features of dominant and recessive interferon γ receptor 1 deficiencies. The Lancet. 364(9451). 2113–2121. 294 indexed citations
19.
Holland, Steven M.. (2001). Cytokine therapeutics in infectious diseases. Lippincott Williams & Wilkins eBooks. 8 indexed citations
20.
Boisson‐Dupuis, Stéphanie, Catherine Dargemont, Claire Fieschi, et al.. (2001). Impairment of Mycobacterial But Not Viral Immunity by a Germline Human STAT1 Mutation. Science. 293(5528). 300–303. 374 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anthony S. Fauci Breakdown of academic impact, for papers by Yehuda Shoenfeld Breakdown of academic impact, for papers by Barry R. Bloom Breakdown of academic impact, for papers by David Y. Graham Breakdown of academic impact, for papers by Alain Fischer Breakdown of academic impact, for papers by H. Clifford Lane Breakdown of academic impact, for papers by Akiko Iwasaki Breakdown of academic impact, for papers by Philip R. Taylor Breakdown of academic impact, for papers by Stefan Schreiber Breakdown of academic impact, for papers by Arturo Casadevall
Rankless by CCL
2026